Are Challenge Trials Ethical for COVID-19? with Richard Yetter Chappell @ Pod of Asclepius

preview_player
Показать описание
Richard Yetter Chappell (University of Miami) discusses his recent article (with Peter Singer) on the ethics of a COVID-19 challenge trial.

0:00 Intro
0:19 The ethics of challenge trials
1:17 Hello to Richard Yetter Chappell
2:12 What sparked the challenge trial article?
2:52 Disconnect: Social ethics vs bio-ethics
4:42 What is a challenge trial?
6:35 What was the Richard Chappell / Peter Singer position of challenge trial?
8:00 Differential risk: trial subjects vs general public
9:55 Word of the day: "ex-ante" risk
10:48 What are the counter arguments to challenge trials?
13:00 Overton window of philosophical positions
14:35 Is understanding risk sufficient for informed patient consent?
18:00 GI Joe Fallacy
22:00 Is understanding benefits necessary for informed patient consent?
23:25 Ethics of inconclusive studies
25:55 Ethics of Type 1 vs Type 2 statistical errors
30:35 Further reading
Рекомендации по теме
Комментарии
Автор

0:00 Intro
0:19 The ethics of challenge trials
1:17 Hello to Richard Yetter Chappell
2:12 What sparked the challenge trial article?
2:52 Disconnect: Social ethics vs bio-ethics
4:42 What is a challenge trial?
6:35 What was the Richard Chappell / Peter Singer position of challenge trial?
8:00 Differential risk: trial subjects vs general public
9:55 Word of the day: "ex-ante" risk
10:48 What are the counter arguments to challenge trials?
13:00 Overton window of philosophical positions
14:35 Is understanding risk sufficient for informed patient consent?
18:00 GI Joe Fallacy
22:00 Is understanding benefits necessary for informed patient consent?
23:25 Ethics of inconclusive studies
25:55 Ethics of Type 1 vs Type 2 statistical errors
30:35 Further reading

datasciencewithglenwrightc